Aberdeen Group plc Acquires 30,723 Shares of Amdocs Limited $DOX

Aberdeen Group plc boosted its holdings in Amdocs Limited (NASDAQ:DOXFree Report) by 13.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 263,287 shares of the technology company’s stock after buying an additional 30,723 shares during the quarter. Aberdeen Group plc owned approximately 0.24% of Amdocs worth $21,197,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Harbor Capital Advisors Inc. bought a new position in shares of Amdocs in the third quarter worth about $26,000. Root Financial Partners LLC bought a new stake in shares of Amdocs during the third quarter worth $26,000. WealthCollab LLC grew its stake in shares of Amdocs by 94.5% during the third quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock worth $29,000 after buying an additional 173 shares during the last quarter. Atlantic Union Bankshares Corp acquired a new position in shares of Amdocs during the third quarter worth $37,000. Finally, Abich Financial Wealth Management LLC acquired a new position in shares of Amdocs during the third quarter worth $39,000. Institutional investors own 92.02% of the company’s stock.

Amdocs Price Performance

Shares of NASDAQ DOX opened at $66.43 on Monday. The company’s 50 day moving average price is $69.72 and its 200-day moving average price is $77.05. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06. Amdocs Limited has a 52-week low of $63.33 and a 52-week high of $95.41. The company has a market capitalization of $7.17 billion, a P/E ratio of 12.85, a price-to-earnings-growth ratio of 1.17 and a beta of 0.46.

Amdocs (NASDAQ:DOXGet Free Report) last posted its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The company had revenue of $1.16 billion during the quarter, compared to analysts’ expectations of $1.15 billion. During the same period in the prior year, the company posted $1.66 earnings per share. Amdocs’s revenue for the quarter was up 4.1% compared to the same quarter last year. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Equities analysts forecast that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be issued a $0.569 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.4%. This is an increase from Amdocs’s previous quarterly dividend of $0.53. Amdocs’s dividend payout ratio (DPR) is 44.10%.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Barclays cut their price target on Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 4th. Stifel Nicolaus dropped their price objective on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Finally, Wall Street Zen cut shares of Amdocs from a “buy” rating to a “hold” rating in a research note on Saturday, March 21st. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $92.33.

Get Our Latest Research Report on DOX

Amdocs Company Profile

(Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

See Also

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.